Campaign funds help steer U.S. stance on drug patents
Pharmaceutical companies shelled out more than $50 million to help Republicans win control of Congress last November. Days after the election, when international trade talks threatened their
Pharmaceutical companies shelled out more than $50 million to help Republicans win control of Congress last November. Days after the election, when international trade talks threatened their